Royal Bank of Canada’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16K Buy
1,692
+1,014
+150% +$11.2K ﹤0.01% 6443
2026
Q1
$8K Sell
678
-992
-59% -$13.1K ﹤0.01% 6259
2025
Q4
$25K Sell
1,670
-187,474
-99% -$2.86M ﹤0.01% 5921
2025
Q3
$2.77M Sell
189,144
-4,082
-2% -$53.6K ﹤0.01% 3142
2025
Q2
$2.15M Buy
193,226
+189,912
+5,731% +$2.35M ﹤0.01% 3232
2025
Q1
$54K Sell
3,314
-1,139
-26% -$20K ﹤0.01% 5544
2024
Q4
$77K Sell
4,453
-27
-0.6% -$469 ﹤0.01% 5475
2024
Q3
$70K Sell
4,480
-155
-3% -$2.48K ﹤0.01% 5542
2024
Q2
$62K Buy
4,635
+2,133
+85% +$29.2K ﹤0.01% 5543
2024
Q1
$36K Sell
2,502
-10,615
-81% -$147K ﹤0.01% 5673
2023
Q4
$177K Buy
13,117
+5,412
+70% +$63.6K ﹤0.01% 5205
2023
Q3
$99K Buy
7,705
+1,758
+30% +$31.6K ﹤0.01% 5390
2023
Q2
$107K Buy
5,947
+1,714
+40% +$32K ﹤0.01% 5283
2023
Q1
$71K Buy
4,233
+1,999
+89% +$39.1K ﹤0.01% 5425
2022
Q4
$45K Buy
2,234
+1,998
+847% +$35.2K ﹤0.01% 5946
2022
Q3
$5K Buy
236
+127
+117% +$2.86K ﹤0.01% 6739
2022
Q2
$3K Sell
109
-1,053
-91% -$30.2K ﹤0.01% 6844
2022
Q1
$38K Sell
1,162
-1,599
-58% -$51.4K ﹤0.01% 6262
2021
Q4
$86K Buy
2,761
+810
+42% +$27.1K ﹤0.01% 6046
2021
Q3
$74K Buy
1,951
+656
+51% +$26.1K ﹤0.01% 5914
2021
Q2
$52K Buy
1,295
+1,294
+129,400% +$54.7K ﹤0.01% 6014
2021
Q1
$0 Sell
1
-7,449
-100% -$328K ﹤0.01% 7609
2020
Q4
$321K Buy
7,450
+143
+2% +$5.22K ﹤0.01% 4490
2020
Q3
$228K Buy
7,307
+100
+1% +$3.1K ﹤0.01% 4455
2020
Q2
$231K Sell
7,207
-26
-0.4% -$863 ﹤0.01% 4354
2020
Q1
$203K Buy
7,233
+6,229
+620% +$241K ﹤0.01% 4325
2019
Q4
$46K Buy
1,004
+917
+1,054% +$43.1K ﹤0.01% 5495
2019
Q3
$5K Buy
+87
New +$4.49K ﹤0.01% 6032
2019
Q2
Sell
-23
Closed -$1K 7083
2019
Q1
$1K Buy
23
+6
+35% +$337 ﹤0.01% 6669
2018
Q4
$1K Sell
17
-492
-97% -$28K ﹤0.01% 6593
2018
Q3
$29K Buy
509
+170
+50% +$9.53K ﹤0.01% 5502
2018
Q2
$19K Buy
339
+337
+16,850% +$19.2K ﹤0.01% 5561
2018
Q1
$0 Sell
2
-20
-91% -$1.12K ﹤0.01% 6663
2017
Q4
$1K Sell
22
-1,574
-99% -$81.6K ﹤0.01% 6407
2017
Q3
$75K Buy
1,596
+1,532
+2,394% +$72.1K ﹤0.01% 5201
2017
Q2
$3K Sell
64
-459
-88% -$19K ﹤0.01% 6197
2017
Q1
$20K Sell
523
-557
-52% -$20.6K ﹤0.01% 5622
2016
Q4
$39K Sell
1,080
-5,845
-84% -$222K ﹤0.01% 5406
2016
Q3
$296K Sell
6,925
-3,363
-33% -$150K ﹤0.01% 4150
2016
Q2
$436K Sell
10,288
-2,625
-20% -$114K ﹤0.01% 3815
2016
Q1
$536K Buy
12,913
+2,828
+28% +$111K ﹤0.01% 3592
2015
Q4
$396K Buy
10,085
+9,178
+1,012% +$343K ﹤0.01% 3991
2015
Q3
$31K Sell
907
-343
-27% -$12.2K ﹤0.01% 5376
2015
Q2
$42K Buy
1,250
+644
+106% +$22.1K ﹤0.01% 5317
2015
Q1
$21K Buy
606
+383
+172% +$12K ﹤0.01% 5335
2014
Q4
$7K Buy
223
+28
+14% +$821 ﹤0.01% 5717
2014
Q3
$6K Sell
195
-47
-19% -$1.56K ﹤0.01% 5611
2014
Q2
$9K Hold
242
﹤0.01% 5440
2014
Q1
$7K Sell
242
-334
-58% -$7.7K ﹤0.01% 5516
2013
Q4
$14K Sell
576
-6,673
-92% -$139K ﹤0.01% 5377
2013
Q3
$150K Buy
7,249
+4,431
+157% +$108K ﹤0.01% 4252
2013
Q2
$76K Buy
+2,818
New +$84.4K ﹤0.01% 4449

Other funds holding OFIX

Royal Bank of Canada's OFIX Position: Q2 2026 in Review

Royal Bank of Canada increased its Orthofix Medical (OFIX) stake by 150% in Q2 2026, buying an estimated $11.2K and bringing the position to 1,692 shares worth $16K. The position accounts for ﹤0.01% of the portfolio, ranked #6443.

Royal Bank of Canada first reported a position in OFIX in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.77M in Q3 2025. 143 funds tracked by Wall St. Rank hold OFIX as of Q2 2026.

  • Royal Bank of Canada held 1,692 shares of Orthofix Medical worth $16K as of Q2 2026.
  • Royal Bank of Canada bought 1,014 Orthofix Medical shares in Q2 2026, an estimated $11.2K.
  • Orthofix Medical made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #6443 holding.
  • Royal Bank of Canada first reported a position in Orthofix Medical in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's Orthofix Medical position peaked at $2.77M in Q3 2025.
  • 143 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.